Literature DB >> 25819486

Imaging regional lung function: a critical tool for developing inhaled antimicrobial therapies.

Stephen Dubsky1, Andreas Fouras2.   

Abstract

Alterations in regional lung function due to respiratory infection have a significant effect on the deposition of inhaled treatments. This has consequences for treatment effectiveness and hence recovery of lung function. In order to advance our understanding of respiratory infection and inhaled treatment delivery, we must develop imaging techniques that can provide regional functional measurements of the lung. In this review, we explore the role of functional imaging for the assessment of respiratory infection and development of inhaled treatments. We describe established and emerging functional lung imaging methods. The effect of infection on lung function is described, and the link between regional disease, function, and inhaled treatments is discussed. The potential for lung function imaging to provide unique insights into the functional consequences of infection, and its treatment, is also discussed.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Computed tomography; Deposition; Functional imaging; Phase contrast; Respiratory infection; X-ray imaging

Mesh:

Substances:

Year:  2015        PMID: 25819486     DOI: 10.1016/j.addr.2015.03.010

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  10 in total

1.  Effect of static vs. dynamic imaging on particle transport in CT-based numerical models of human central airways.

Authors:  Shinjiro Miyawaki; Eric A Hoffman; Ching-Long Lin
Journal:  J Aerosol Sci       Date:  2016-07-16       Impact factor: 3.433

2.  The Creation and Statistical Evaluation of a Deterministic Model of the Human Bronchial Tree from HRCT Images.

Authors:  Spyridon Montesantos; Ira Katz; Marine Pichelin; Georges Caillibotte
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

3.  Quantification of image texture in X-ray phase-contrast-enhanced projection images of in vivo mouse lungs observed at varied inflation pressures.

Authors:  Frank J Brooks; Sean P Gunsten; Sunil K Vasireddi; Steven L Brody; Mark A Anastasio
Journal:  Physiol Rep       Date:  2019-08

Review 4.  The physics of respiratory particle generation, fate in the air, and inhalation.

Authors:  Lidia Morawska; Giorgio Buonanno; Alex Mikszewski; Luca Stabile
Journal:  Nat Rev Phys       Date:  2022-08-31

5.  Defect distribution index: A novel metric for functional lung MRI in cystic fibrosis.

Authors:  Anne Valk; Corin Willers; Kamal Shahim; Orso Pusterla; Grzegorz Bauman; Robin Sandkühler; Oliver Bieri; Florian Wyler; Philipp Latzin
Journal:  Magn Reson Med       Date:  2021-08-02       Impact factor: 3.737

Review 6.  Lung function imaging methods in Cystic Fibrosis pulmonary disease.

Authors:  Magdalena Kołodziej; Michael J de Veer; Marian Cholewa; Gary F Egan; Bruce R Thompson
Journal:  Respir Res       Date:  2017-05-17

7.  In vivo Dynamic Phase-Contrast X-ray Imaging using a Compact Light Source.

Authors:  Regine Gradl; Martin Dierolf; Benedikt Günther; Lorenz Hehn; Winfried Möller; David Kutschke; Lin Yang; Martin Donnelley; Rhiannon Murrie; Alexander Erl; Tobias Stoeger; Bernhard Gleich; Klaus Achterhold; Otmar Schmid; Franz Pfeiffer; Kaye Susannah Morgan
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

8.  Infrared Hollow Optical Fiber Probe for Localized Carbon Dioxide Measurement in Respiratory Tracts.

Authors:  Takashi Katagiri; Kyosuke Shibayama; Takeru Iida; Yuji Matsuura
Journal:  Sensors (Basel)       Date:  2018-03-27       Impact factor: 3.576

Review 9.  Imaging of pulmonary perfusion using subtraction CT angiography is feasible in clinical practice.

Authors:  Dagmar Grob; Luuk J Oostveen; Mathias Prokop; Cornelia M Schaefer-Prokop; Ioannis Sechopoulos; Monique Brink
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

10.  An Inhalable Theranostic System for Local Tuberculosis Treatment Containing an Isoniazid Loaded Metal Organic Framework Fe-MIL-101-NH2-From Raw MOF to Drug Delivery System.

Authors:  Gabriela Wyszogrodzka-Gaweł; Przemysław Dorożyński; Stefano Giovagnoli; Weronika Strzempek; Edyta Pesta; Władysław P Węglarz; Barbara Gil; Elżbieta Menaszek; Piotr Kulinowski
Journal:  Pharmaceutics       Date:  2019-12-17       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.